TY - JOUR
T1 - The Influence of Relative Humidity and Storage Conditions on the Physico-chemical Properties of Inhalation Grade Fine Lactose
AU - Stankovic-Brandl, Milica
AU - Zellnitz, Sarah
AU - Wirnsberger, Paul
AU - Kobler, Mirjam
AU - Paudel, Amrit
N1 - Funding Information:
This study was funded by the Austrian COMET Programme under the auspices of the Austrian Federal Ministry of Transport, Innovation and Technology (BMVIT), the Austrian Federal Ministry of Economy, Family and Youth (BMWFJ), and the State of Styria (Styrian Funding Agency [SFG]). COMET is managed by the Austrian Research Promotion Agency (FFG).
Publisher Copyright:
© 2021, The Author(s), under exclusive licence to American Association of Pharmaceutical Scientists.
PY - 2022/1
Y1 - 2022/1
N2 - Dry powder inhalers (DPIs) are favorable devices for the delivery of dry formulations to the lungs; still, they largely fail to deliver higher doses of active pharmaceutical ingredient (API) to the lower airways. Addition of fine particles of excipient (fines) to the blend of API and carrier was shown to improve aerosolization performance. Lactose monohydrate is ubiquitous excipient used for this purpose. Lactose exists in a thermodynamically stable crystalline form; however, processes like milling, sieving, or even mixing may induce alteration of crystalline structure and introduce amorphous domains, which could further affect the physico-chemical properties of the material. Therefore, the aim of this work is a detailed characterization of two commercially available types of inhalation grade fine lactose powders (Inhalac 400 and Inhalac 500) prepared using different air-jet milling parameters, with a focus on impact of storage conditions on material properties. We found that the different milling parameters resulted in variable particle size distribution (PSD), and thus surface areas, variable initial amorphous content, cohesivity, flowability, and moisture sorption of materials. In addition, exposure of fine powders to higher humidity reduced the amorphous content present in the materials, but also affected agglomeration tendency and dispersion behavior of both powders. We believe the obtained findings to be important for the aerosolization performance of carrier-based DPIs containing fines and thus need to be duly considered during formulation development. Graphical Abstract: [Figure not available: see fulltext.]
AB - Dry powder inhalers (DPIs) are favorable devices for the delivery of dry formulations to the lungs; still, they largely fail to deliver higher doses of active pharmaceutical ingredient (API) to the lower airways. Addition of fine particles of excipient (fines) to the blend of API and carrier was shown to improve aerosolization performance. Lactose monohydrate is ubiquitous excipient used for this purpose. Lactose exists in a thermodynamically stable crystalline form; however, processes like milling, sieving, or even mixing may induce alteration of crystalline structure and introduce amorphous domains, which could further affect the physico-chemical properties of the material. Therefore, the aim of this work is a detailed characterization of two commercially available types of inhalation grade fine lactose powders (Inhalac 400 and Inhalac 500) prepared using different air-jet milling parameters, with a focus on impact of storage conditions on material properties. We found that the different milling parameters resulted in variable particle size distribution (PSD), and thus surface areas, variable initial amorphous content, cohesivity, flowability, and moisture sorption of materials. In addition, exposure of fine powders to higher humidity reduced the amorphous content present in the materials, but also affected agglomeration tendency and dispersion behavior of both powders. We believe the obtained findings to be important for the aerosolization performance of carrier-based DPIs containing fines and thus need to be duly considered during formulation development. Graphical Abstract: [Figure not available: see fulltext.]
KW - Charge
KW - Flowability
KW - Inhalation fines
KW - Lactose
KW - Storage
KW - Water content
UR - http://www.scopus.com/inward/record.url?scp=85119401882&partnerID=8YFLogxK
U2 - 10.1208/s12249-021-02159-8
DO - 10.1208/s12249-021-02159-8
M3 - Article
C2 - 34791545
AN - SCOPUS:85119401882
SN - 1530-9932
VL - 23
JO - AAPS PharmSciTech
JF - AAPS PharmSciTech
IS - 1
M1 - 1
ER -